Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
88.00    0.00 (0.00%)
Bid:
86.00
Ask:
90.00
Spread: 4.00 (4.651%)
Market Cap: £98.77m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Trading Update

13 Jan 2026 07:00

RNS Number : 5824O
Brave Bison Group PLC
13 January 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

13 January 2026

 

Brave Bison Group plc

 

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

 

Trading Update

 

FY25 trading ahead of consensus

following strong Q4 in Sport & Entertainment

 

Year end net cash of £4.3m significantly ahead of consensus

 

Brave Bison, the next-generation marketing and technology partner for global brands, is pleased to provide the following trading update for the year ending 31 December 2025 ("FY25") ahead of publication of the Group's audited FY25 results.

 

Financial Highlights

 

Year ending 31 December

FY25(1)

FY24

Change

Net Revenue

£33.5m

£21.3m

+57%

Adj. EBITDA(2)

£6.5m

£4.5m

+44%

Adj. Profit Before Tax(3)

£5.5m

£3.9m

+41%

Net Cash(4)

£4.3m

£7.5m

(42%)

Subject to audit, small apparent errors due to rounding

 

§ Net revenue of not less than £33.5m (FY24: £21.3m), ahead of consensus expectations(5) and growth of 57% year-on-year

 

§ Adj. EBITDA of not less than £6.5m (FY24: £4.5m) and Adj. Profit Before Tax of not less than £5.5m (FY24: £3.9m), an increase of 44% and 41%, respectively, year-on-year and both ahead of consensus expectations(5)

 

§ Net cash at year end of £4.3m (FY24: £7.5m), significantly ahead of consensus expectations(5) following strong Q4 trading and an improved working capital position which is expected to partially unwind over the first half of 2026

 

Outlook

 

As a result of strong trading in the second half of FY25, the Board now expects to be in a position to repay all outstanding bank debt prior to the end of 2026, meaning that debt facilities drawn to fund acquisitions completed in H2 2025 will be repaid ahead of prior expectations.

 

Free cashflow generated in excess of loan repayments will be used to fund further acquisitions, and the payment of dividend(s), in-line with the Company's capital allocation policy.

 

The Board is comfortable with FY26 consensus expectations(5) of £45m of net revenue and £9.4m of Adj. EBITDA.

 

As a result of the timing of MiniMBA courses (running April to July and September to December) the Group's revenue and profit profile is now expected to be more heavily weighted to the second half of each year than has historically been the case.

 

(1) Unaudited, not less than results.

(2) Adj. EBITDA is defined as earnings before interest, taxation, depreciation and amortisation, and after adding back acquisition costs, restructuring costs and share-based payments. Under IFRS16 most of the costs associated with property leases are classified as depreciation and interest, therefore Adj. EBITDA is stated before deducting these costs.

(3) Adj. Profit Before Tax is stated after adding back acquisition costs, restructuring costs, impairments, amortisation of acquired intangibles and share-based payments, and is after the deduction of costs associated with property leases.

(4) Net Cash is stated before deducting lease liabilities and deferred consideration

(5) Company compiled FY25 consensus expectations immediately prior to this announcement: net revenue of £31.5m / Adj. EBITDA of £6.1m / Adj. PBT of £5.2m / net debt £3.6m

 

For further information please contact:  

 

Brave Bison Group plc via Cavendish 

Oliver Green, Executive Chairman  

Theo Green, Chief Growth Officer  

Philippa Norridge, Chief Financial Officer  

 

Cavendish Capital Markets Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM

 

Singer Capital Markets Tel: +44 (0) 20 7496 3000 

Joint Broker  

Alex Bond / Sara Hale

 

About Brave Bison 

 

Brave Bison is a marketing and technology partner for global brands. With operations across eight countries including the UK, India, Australia and Egypt, Brave Bison provides customers with digital services, digital media and marketing skills training. 

 

The Group operates through two divisions: Digital Services and Digital Content.

 

Digital Services comprises the Group's digital marketing operations. Trading through dedicated brands including Brave Bison (performance media), SocialChain (social & influencer marketing), Engage (Sport & Entertainment) and MTM (strategy & insight), the Group works with global brands and media rights holders across consultancy and execution. Customers include New Balance, Primark and Google, as well as Formula 1, Real Madrid and New Zealand Rugby. 

 

Digital Content comprises the Group's operations to monetise digital content through training and advertising. This division includes the Brave Bison media network of YouTube, Facebook and Snap channels, as well as MiniMBA, a marketing skills and training platform that provides MBA-level education through an online learning portal. Almost 6,000 marketing professionals take MiniMBA courses every year and the platform has trained over 40,000 delegates since inception. MiniMBA sells directly to marketers through its website, as well as to enterprise customers looking to upskill their teams including American Express, McDonald's, Google, British Airways, Nestle and Salesforce. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFLFWEEMSESF
Date   Source Headline
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
17th Jul 20255:27 pmRNSHolding(s) in Company
17th Jul 20258:21 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.